Benzinga

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Benzinga

Premium Services
Financial News
Financial News
Large Cap Stocks
Small-Cap Stocks
Insider Trades
Earnings
Technology
AI News
Personal Finance
ETF News
Crypto News
Dividend News
Latest Rumors
Latest Offerings News
Investment Ideas
Investment Ideas
Stock of the Day
Stock Whisper Index
Analyst Ratings
Analyst Color
Financial Advisors
Government Trades
Trading Ideas
Stock Screener
Markets
Markets
Premarket Movers
After Hours
Options
ETFs
Commodities
Prediction Markets
Private Markets
Bonds
Futures
Forex
Top Stocks
Top Stocks
Apple (AAPL)
Tesla (TSLA)
Amazon (AMZN)
Nvidia (NVDA)
Alphabet (GOOGL)
Meta Platforms (META)
Microsoft (MSFT)
StreetTracks Gold Shares (GLD)
IBIT Bitcoin Trust (IBIT)
Top Value Stocks
Top Momentum Stocks
Top Growth Stocks
Top Quality Stocks
Learn
Learn
Investing Guides
Personal Finance
Mortgages
Best Credit Cards
Best Dividend Stocks
Best Swing Trade Stocks

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

Reckitt Benckiser Group PLC Stock News

RBGPFOTCQX

Trade with Public

Trade with Public

$60.85

-0.15-0.25%

Last update: May 13, 9:54 AM

OverviewNewsShort Interest

Latest Reckitt Benckiser Group Stock News | OTC:RBGPF | Benzinga

Get the latest news on Reckitt Benckiser Group stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Reckitt Benckiser Group performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, November 08, 2024

FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns
Vandana Singh

Wednesday, September 18, 2024

Consumer Giant Reckitt Seeks Help From Investment Banks To Evaluate Options For Homecare Brands, Baby Formula
Vandana Singh

Monday, July 08, 2024

Similac Baby Formula Maker Abbott And Reckitt Face Hundreds Of Baby Formula Lawsuits
Vandana Singh

Friday, March 15, 2024

What's Going On With Abbott Laboratories Stock On Friday?
Vandana Singh

Thursday, February 29, 2024

Durex Owner Reckitt Benckiser Taps Into China's Livestreaming Trend To Sell Condoms Online
Benzinga Neuro

Tuesday, September 12, 2023

FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
Vandana Singh

Wednesday, May 24, 2023

Is There Collusion in the Baby-Formula Industry?: FTC Scrutinizes State Contracts Bidding Process
Vandana Singh

Friday, December 02, 2022

Reckitt Sees US Baby Food Formula Crisis Persisting Till Spring: Report
Anusuya Lahiri

Thursday, September 01, 2022

Dettol Maker Reckitt Benckiser's CEO Steps Down
Shivani Kumaresan

Thursday, August 11, 2022

Baby Formula Startup Seeks To Compete Abbott With 15% Market Share: Report
Vandana Singh

Wednesday, July 27, 2022

Reckitt Lifts Annual Forecast On Higher Prices, Baby Formula Shortage
Vandana Singh

Wednesday, May 25, 2022

More Companies Join Race To Ease US Baby Formula Supply Crunch
Vandana Singh

Friday, May 20, 2022

Danone Scales Up Baby Formula Shipments To US To Combat Shortage: Reuters
Vandana Singh

Friday, April 29, 2022

Morning Brief: Top Financial Stories Dominating on Friday, April 29
Akanksha Bakshi
Reckitt Benckiser Hikes Prices To Compensate For Falling Demand: FT
Shivani Kumaresan

Thursday, October 26, 2017

Wall Street's M&A Chatter From October 25: Sprint-T-Mobile, Trade Desk, Pfizer, Dynegy
Benzinga

Monday, July 17, 2017

Wall Street's M&A Chatter From July 14-16: Dominion Diamond, Unilever-Hormel-Reckitt, H&E Equipment-Neff, Mobileye-Intel
Benzinga

Thursday, May 01, 2014

Benzinga's M&A Chatter for Thursday May 1, 2014
Benzinga

Wednesday, April 30, 2014

Reckitt Benckiser Confirms it is No Longer in Talks with Merck Regarding Bid for Consumer Health Business
Benzinga

Monday, April 28, 2014

Benzinga's M&A Chatter for Monday April 28, 2014
Benzinga
Reckitt Benckiser Confirms Talks With Merck Regarding Bid for Consumer Health Business, Bayer Also Rumored Bidder
Benzinga
Benzinga's Weekend M&A Chatter
Benzinga

Saturday, April 26, 2014

Reuters Reports Merck in Talks to Sell Consumer Health Unit to Bayer, Reckitt Benckiser for Approximately $14B, According to Sources
Benzinga

Friday, November 22, 2013

Reuters Reports Reckitt Benckiser Hires Morgan Stanley to Advise on Options for Pharma Unit
Benzinga

Wednesday, September 11, 2013

Reckitt Benckiser CEO Rakesh Kapoor Says Company has Ability to do Large M&A -Reuters
Benzinga

Thursday, November 22, 2012

Benzinga's M&A Chatter for Wednesday November 21, 2012
Benzinga

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2026 Benzinga | All Rights Reserved